Abstract
Induced mouse models of systemic lupus erythematosus (SLE) have been developed to complement the spontaneous models. This chapter describes the methods used in the pristane-induced model and the chronic graft-versus-host disease (cGVHD) model, both of which have been extensively used. We will also outline the specific mechanisms of systemic autoimmunity that can be best characterized using each of these models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sang A, Yin Y, Zheng Y-Y, Morel L (2012) Animal models of molecular pathology: systemic lupus erythematosus. In: Conn PM (ed) Progress in molecular biology and translational science, vol 105. Academic Press, New York, pp 321–370
Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L (2009) Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 30:455–464
Satoh M, Reeves WH (1994) Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 180:2341–2346
Satoh M, Treadwell EL, Reeves WH (1995) Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera. J Immunol Meth 182:51–62
Nacionales DC, Kelly-Scumpia KM, Lee PY, Weinstein JS, Lyons R, Sobel E et al (2007) Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 56:3770–3783
Hooks J, Moutsopoulos H, Geis S, Stahl N, Decker J, Notkins A (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301:5–8
Satoh M, Kuroda Y, Yoshida H, Behney KM, Mizutani A, Akaogi J et al (2003) Induction of lupus autoantibodies by adjuvants. J Autoimmun 21:1–9
Kuroda Y, Nacionales DC, Akaogi J, Reeves WH, Satoh M (2004) Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 58:325–337
Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J et al (2008) TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med 205:2995–3006
Xu Y, Lee PY, Li Y, Liu C, Zhuang H, Han S et al (2012) Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus. J Immunol 188:4113–4121
Barker TT, Lee PY, Kelly-Scumpia KM, Weinstein JS, Nacionales DC, Kumagai Y et al (2011) Pathogenic role of B cells in the development of diffuse alveolar hemorrhage induced by pristane. Lab Invest 91:1540–1550
Lee PY, Weinstein JS, Nacionales DC, Scumpia PO, Li Y, Butfiloski E et al (2008) A novel type I IFN-producing cell subset in murine lupus. J Immunol 180:5101–5108
Lee PY, Li Y, Kumagai Y, Xu Y, Weinstein JS, Kellner ES et al (2009) Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol 175:2023–2033
Nacionales DC, Kelly KM, Lee PY, Zhuang H, Li Y, Weinstein JS et al (2006) Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane). Am J Pathol 168:1227–1240
Lee PY, Li Y, Richards HB, Chan FS, Zhuang H, Narain S et al (2007) Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 56:3759–3769
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408
Hamilton KJ, Satoh M, Swartz J, Richards HB, Reeves WH (1998) Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. Clin Immunol Immunopathol 86:271–279
Soloviova K, Puliaiev M, Foster A, Via C (2012).The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function. In: Perl A (ed) Methods in molecular biology. Methods in molecular biology, vol 900. Humana Press, Totowa, NJ, pp 253–270.
Christadoss P, Lindstrom JM, Melvold RW, Talal N (1985) Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis. Immunogenetics 21:33–38
Naiki M, Yoshida SH, Watanabe Y, Izui S, Ansari AA, Gershwin ME (1993) The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice. J Autoimmun 6:131–143
Rolink AG, Pals ST, Gleichmann E (1983) Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. J Exp Med 157:755–771
Morris SC, Cohen PL, Eisenberg RA (1990) Experimental induction of systemic lupus erythematosus by recognition of foreign Ia. Clin Immunol Immunopathol 57:263–273
Morris SC, Cheek RL, Cohen PL, Eisenberg RA (1990) Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease. J Immunol 144:916–922
Morris SC, Cheek RL, Cohen PL, Eisenberg RA (1990) Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med 171:503–517
Reap EA, Sobel ES, Jennette JC, Cohen PL, Eisenberg RA (1993) Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. J Immunol 151:7316–7323
Choudhury A, Cohen PL, Eisenberg RA (2007) Mature B cells preferentially lose tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J Immunol 179:5564–5570
Chen F, Maldonado MA, Madaio M, Eisenberg RA (1998) The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. J Immunol 161:5880–5885
Choudhury A, Maldonado MA, Cohen PL, Eisenberg RA (2005) The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 174:7600–7609
Choudhury A, Cohen PL, Eisenberg RA (2010) B cells require “nurturing” by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus. Clin Immunol 136:105–115
Ma Z, Chen F, Madaio MP, Cohen PL, Eisenberg RA (2006) Modulation of autoimmunity by TLR9 in the chronic graft-vs-host model of systemic lupus erythematosus. J Immunol 177:7444–7450
Cuda CM, Zeumer L, Sobel ES, Croker BP, Morel L (2010) Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells. Genes Immun 11:542–553
Satoh M, Kumar A, Kanwar YS, Reeves WH (1995) Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A 92:10934–10938
Satoh M, Hamilton KJ, Ajmani AK, Dong X, Wang J, Kanwar YS et al (1996) Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol 157:3200–3206
Chowdhary VR, Grande JP, Luthra HS, David CS (2007) Characterization of haemorrhagic pulmonary capillaritis: another manifestation of pristane-induced lupus. Rheumatology (Oxford) 46:1405–1410
Smith DL, Dong X, Du S, Oh M, Singh RR, Voskuhl RR (2007) A female preponderance for chemically induced lupus in SJL/J mice. Clin Immunol 122:101–107
Li Y, Lee PY, Kellner ES, Paulus M, Switanek J, Xu Y et al (2010) Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus. Arthritis Res Ther 12:R90
Shao W-H, Eisenberg RA, Cohen PL (2008) The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J Immunol 180:7728–7735
Keszei M, Detre C, Rietdijk ST, Munoz P, Romero X, Berger SB et al (2011) A novel isoform of the Ly108 gene ameliorates murine lupus. J Exp Med 208:811–822
Zhao Z, Burkly LC, Campbell S, Schwartz N, Molano A, Choudhury A et al (2007) TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 179:7949–7958
Xie C, Sharma R, Wang H, Zhou XJ, Mohan C (2004) Strain distribution pattern of susceptibility to immune-mediated nephritis. J Immunol 172:5047–5055
Feuerstein N, Chen F, Madaio M, Maldonado M, Eisenberg RA (1999) Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J Immunol 163:5287–5297
Feuerstein N, Shivers D, Chen F, Eisenberg RA, Finkel TH (2003) Chronic GVH prevents anergy in bone marrow self‐reactive B cells: a selective increase in post‐endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors. Int Immunol 15:975–985
Feuerstein N, DeSimone DC, Eisenberg RA, Finkel TH (2004) Chronic graft-versus-host reaction is associated with a decrease in Ig light chain receptor editing in bone marrow self-reactive B cells. Eur J Immunol 34:1361–1370
Sekiguchi DR, Jainandunsing SM, Fields ML, Maldonado MA, Madaio MP, Erikson J et al (2002) Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol 168:4142–4153
Sekiguchi DR, Eisenberg RA, Weigert M (2003) Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells. J Exp Med 197:27–39
Witsch EJ, Cao H, Fukuyama H, Weigert M (2006) Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med 203:1761–1772
Shao W-H, Zhen Y, Finkelman FD, Eisenberg RA, Cohen PL (2012) Intrinsic unresponsiveness of Mertk−/− B cells to chronic graft-versus-host disease is associated with unmodulated CD1d expression. J Autoimmun 39:412–419
Nguyen V, Luzina I, Rus H, Tegla C, Chen C, Rus V (2012) IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms. J Immunol 189:1081–1093
Xu Z, Vallurupalli A, Fuhrman C, Ostrov D, Morel L (2011) An NZB-derived locus suppresses chronic graft versus host disease and autoantibody production through non-lymphoid bone-marrow derived cells. J Immunol 186:4130–4139
Molano A, Lakhani P, Aran A, Burkly LC, Michaelson JS, Putterman C (2009) TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis. Immunol Lett 125:119–128
Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219–229
Morel L (2012) Mapping lupus susceptibility genes in the NZM2410 mouse model. Adv Immunol 115:113–139
Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G et al (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A 97:6670–6675
Morel L, Blenman KR, Croker BP, Wakeland EK (2001) The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A 98:1787–1792
Chen Y, Perry D, Boackle SA, Sobel ES, Molina H, Croker BP et al (2005) Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. J Immunol 175:1080–1089
Perry DJ, Yin Y, Telarico T, Baker HV, Dozmorov I, Perl A et al (2012) Murine lupus susceptibility locus Sle1c2 mediates CD4+ T cell activation and maps to estrogen-related receptor gamma. J Immunol 189:793–803
Boackle SA, Holers VM, Chen XJ, Szakonyi G, Karp DR, Wakeland EK et al (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775–785
Cuda CM, Li S, Liang S, Yin Y, Potula HH, Xu Z et al (2012) Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans. J Immunol 188:604–614
Xu Z, Potula HH, Vallurupalli A, Perry D, Baker H, Croker BP et al (2011) Cyclin-dependent kinase inhibitor Cdkn2c regulates B cell homeostasis and function in the NZM2410-derived murine lupus susceptibility locus Sle2c1. J Immunol 186:6673–6682
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Xu, Y., Zeumer, L., Reeves, W.H., Morel, L. (2014). Induced Murine Models of Systemic Lupus Erythematosus. In: Eggleton, P., Ward, F. (eds) Systemic Lupus Erythematosus. Methods in Molecular Biology, vol 1134. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0326-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0326-9_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0325-2
Online ISBN: 978-1-4939-0326-9
eBook Packages: Springer Protocols